Page 4 - சுவிட்சர்லாந்து கண்டுபிடிப்பு News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Guest Author April 15, 2021 New companies are leading the way. Deep Breath Intelligence, a spin-off from some of the top Swiss universities, is using artificial intelligence to uncover the full potential of Molecular Breath Analysis for precision medicine applications. Diaxxo, founded in 2020 at ETH Zurich, has developed simple and precise Point-of-Care PCR test to help doctors identify and treat diseases faster. Saverna Therapeutics, a company that is just 4 years old, is using the latest artificial intelligence tools and Nuclear Magnetic Resonance to reduce the time and cost of drug discovery. Established companies that are synonymous with Switzerland, such as Novartis, are also playing a vital role in helping to foster this innovation. Just last year,

New yorkUnited statesLake genevaSwitzerland generalSophie cernyAndre guedelNuclear magnetic resonanceSwiss biotech associationEuropean unionBreath intelligenceMolecular breath analysisSwitzerland innovation park basel areaSwitzerland innovationSwiss business hub united statesConsulate generalSwiss business hub